Skip to main content
main-content

01.12.2012 | Research | Ausgabe 1/2012 Open Access

Health and Quality of Life Outcomes 1/2012

Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18)

Zeitschrift:
Health and Quality of Life Outcomes > Ausgabe 1/2012
Autoren:
Naoko Mikoshiba, Ryosuke Tateishi, Makoto Tanaka, Tomoko Sakai, Jane M Blazeby, Norihiro Kokudo, Kazuhiko Koike, Keiko Kazuma
Wichtige Hinweise

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

NM, TS, MT, RT, JMB, NK and KK conceptualized the rationale and design of the study. NM, TS, MT, RT, JMB and KK conducted scale development. NM and TS presented this study to patients and collected data. NM, TS, MT, RT, JMB and KK conducted statistical analyses and interpreted the data. NM, RT, JMB drafted the manuscript. All authors read and approved the final manuscript.

Abstract

Background

This study examined the measurement properties of the Japanese version of the European Organisation for Research and Treatment of Cancer (EORTC) Hepatocellular Carcinoma-Specific Quality of Life Questionnaire (QLQ-HCC18).

Methods

EORTC quality of life (QOL) translation guidelines were followed to create a Japanese version of the EORTC QLQ-HCC18. This was then administered to 192 patients with hepatocellular carcinoma along with the EORTC QLQ-C30 and FACT-Hep questionnaires. Tests for reliability and validity were conducted including comparison of scores between the EORTC and FACT questionnaire and detailed assessment of the new scales and items in clinically distinct groups of patients.

Results

Multi-trait scaling analysis confirmed three putative scales in the QLQ-HCC18, fatigue, fever and nutrition. Cronbach’s alpha for these scales were between 0.68 and 0.78. The QLQ-HCC18 scales correlated with scales measuring similar items in the FACT-Hep and the questionnaire was stable over time with an intra-class correlation score of 0.70 for almost all scales. The questionnaire had the ability to distinguish between patients with different Karnofsky Performance Status, and Child-Pugh liver function class.

Conclusions

The Japanese version of EORTC QLQ-HCC18 is a reliable supplementary measure to use with EORTC QLQ-C30 to measure QOL in Japanese patients with hepatocellular carcinoma.
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2012

Health and Quality of Life Outcomes 1/2012 Zur Ausgabe